US drug industry's guidelines on advertising too limited, say critics

BMJ 2005; 331 doi: 10.1136/bmj.331.7514.420-b (Published 18 August 2005)
Cite this as: BMJ 2005;331:420.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Bob Burton
  1. Canberra

    In the face of growing support for tighter regulations on advertising directly to consumers, the US drug industry's trade association has released voluntary guidelines of its own.

    However, the guidelines fall short of a proposal by the leader of the Republican Senate majority, Bill Frist, for a two year waiting period before any new drug can be advertised directly to consumers. In July Dr …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL